Cargando…
The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice
Since the initial observations by Warburg in 1924, it has become clear in recent years that tumour cells require a high level of glucose to proliferate. Therefore, a ketogenic diet that provides the body with energy mainly through fat and proteins, but contains a reduced amount of carbohydrates, has...
Autores principales: | JANSEN, NATALIE, WALACH, HARALD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726921/ https://www.ncbi.nlm.nih.gov/pubmed/26870251 http://dx.doi.org/10.3892/ol.2015.3923 |
Ejemplares similares
-
The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases
por: Deshpande, Gaurang P., et al.
Publicado: (2019) -
TKTL1 expression in human malign and benign cell lines
por: Kämmerer, Ulrike, et al.
Publicado: (2015) -
Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients
por: Tsaur, Igor, et al.
Publicado: (2016) -
Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients
por: Klement, Rainer J., et al.
Publicado: (2018) -
Scientific evidence underlying contraindications to the ketogenic diet: An update
por: Watanabe, Mikiko, et al.
Publicado: (2020)